{
    "code": "01026939",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01026939",
    "time": "2019-07-19 03:23:18",
    "許可證字號": "衛署藥製字第026939號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/05\/25",
    "發證日期": "72\/03\/04",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102693903",
    "中文品名": "舒化散",
    "英文品名": "BIODAS POWDER",
    "適應症": "幫助消化。",
    "劑型": "140散劑",
    "包裝": "9-1000公克玻璃瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "17醫師藥師藥劑生指示藥品",
    "主成分略述": "NEWLASE, BIODIASTASE 1000, LIPASE",
    "主製造廠": {
        "申請商名稱": "1421417200  壽元化學工業股份有限公司",
        "申請商地址": "嘉義市西區新民路128號",
        "主製造廠": "",
        "製造廠名稱": "1421417300  壽元化學工業股份有限公司"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4400002700",
            "成分名稱": "NEWLASE",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4400007130",
            "成分名稱": "BIODIASTASE 1000",
            "含量描述": "",
            "含量": "60.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "5616000900",
            "成分名稱": "LIPASE",
            "含量描述": "(AP 6)",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "3722-舒化散仿單-104-12-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01026939&Seq=003&Type=9"
        }
    ]
}